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Opportunities for Improving Techniques for
Interspecies Extrapolation in the Risk
Assessment Process
by James E. Gibson* and Thomas B. Starr*
Quantitative estimates of human carcinogenic risk from chemical exposure are currently derived pri-
marily from linearized multistage model analyses ofthe tumor response as observed in chronic laboratory
animal bioassays versus administered dose. The numerous ad hoc assumptions that provide a rationale
forthisgeneric approach tocarcinogenicriskassessmentcanonlybeevaluatedcriticallywhenmechanistic
data directly relevant to the low-dose and interspecies extrapolation problems are available. Clear needs
exist to develop such ancillary data bases and the means for explicitly incorporating them into the risk
estimation process. Target site dosimetry provides one useful organizing concept. Physiological response
modeling can account systematically for interspecies variations in the distribution and disposition of
chemicals in relation to external measures ofexposure. Direct measurements ofinteractions ofchemicals
andtheirmetaboliteswithspecific targetmacromolecules canprovidesensitive andbiologicallymeaningful
exposure indices. Alternatively, quantitation of toxic effects such as altered cell regulation and differ-
entiation can serve the same purpose. Virus and oncogene activation, DNA damage and repair, and
enhanced cell proliferation provide additional biological markers of exposure. They may also comprise
critical elements of the carcinogenic process. Identification of the actual mechanisms involved should
eventually lead to the development ofrisk assessment models that adequately reflect the unique biological
and toxicological characteristics of different species-chemical combinations.
Introduction
At present, regulatory agencies rely primarily on li-
nearized, multistage model analyses of the tumor re-
sponsesobserved inchronic laboratoryanimalbioassays
togenerate quantitative estimates ofhuman cancerrisk
from any chemical exposure. This generic approach to
carcinogenic risk assessment rests on numerous ad hoc
assumptions (1) that are made in the absence ofdetailed
biological and toxicological data regarding the actual
mechanisms of action of chemicals. For example, it is
assumed that the administered dose of a chemical is
directly proportional to the amount or concentration of
the carcinogenically active form of the chemical that
reaches specific target tissue macromolecules. In ad-
dition, after a simple scaling ofexposure levels between
test animals and humans on a body weight or surface
area basis, it is assumed that humans may be at least
as sensitive to the carcinogenic effects of chemicals as
is the most sensitive animal species.
Althoughit maybeanticipated thatassumptions ofsuch
global generality will be incorrect in many specific cases
(2), these assumptions can onlybe evaluated critically and
replaced as necessary with mechanistic data that shed
light on the many complex and interacting factors that
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make the interspecies extrapolation problem so difficult.
The challenge is to develop detailed ancillary data bases
for chemicals that not only reveal their mechanisms of
action, but also permit a scientifically defensible expla-
nation of specific and possibly discrepant study findings
in mechanistic terms. As is clearly illustrated in the fol-
lowing examples drawn from the Chemical Industry In-
stitute of Toxicology (CIIT) research program of meth-
anol, 1,3-butadiene, unleadedgasoline, andformaldehyde,
this approach is likely to be most fruitful where bioassay
and/or shorter term study results indicate significant dif-
ferences in toxic responses to chemical exposure at dif-
ferent dose levels, across sexes, and/or between species.
Methanol
Methanolis amajorindustrialchemicalwithacurrent
annual production in the United States ofover 1 billion
gallons. While the potential for human exposure is con-
siderable, virtually nothing is known regarding toxic
effects of chronic methanol exposure. It has long been
known that acute methanol exposure in humans, pri-
marilybyingestion, mayleadtometabolicacidosis, cen-
tral nervous system depression, blindness, and death.
Research studies designed to characterize animal
models for acute, high-dose methanol toxicity have re-
vealed that the metabolism of methanol differs signifi-100GIBSON AND STARR
cantly across species (3,4). Primates and rodents differ
intheenzyme responsible fortheinitialstepofmethanol
metabolism. Methanol is oxidized to formaldehyde al-
most exclusively by alcohol dehydrogenase in primates,
with catalase playing little or no role. In contrast, the
catalase-peroxidative system is primarily responsible
for the first step in methanol oxidation in rats (5).
Methanol exposure also results in marked elevation
of blood formic acid in humans and monkeys, but no
formate accumulation occursinnormalrats (5). Therate
for formate oxidation to CO2 in rats is twice that in
monkeys (6), and in both species, the metabolism is
dependent on folic acid (6,7). Rats deficient in folic acid
exhibit metabolic acidosis and formic acid accumulation
whentreated with methanol (8). Thesefindings suggest
that the rate of formate oxidation and the folic acid
status are important determinants of the relative sen-
sitivity of different species to acute methanol toxicity.
These studies provide valuable information on acute,
high-dose methanol toxicity. However, the extreme
doses and routes of administration (oral gavage or IP
injection)thatwereusedwouldcallintoseriousquestion
the validity ofanyextrapolations based ontheresulting
datatohumanenvironmentalandoccupationalexposure
conditions, where exposure occurs by inhalation oflow,
airborne concentrations. The current threshold limit
value (TLV) is 200 ppm.
The choice ofa particular animal species as a model for
humans is always an important issue in the design of
chronic toxicity and oncogenicity studies. Usually very
little is known regarding the differences in toxicokinetics
between animal species and humans, but this is not the
case with methanol. Much is known regarding the differ-
ence in toxicokinetics betweenprimates and rodents after
highoral orparenteraldosesandthatknowledge suggests
that the rat may be an inappropriate model for humans.
This would seem to implythat safety evaluations ofmeth-
anol be perfonned with primates rather than with the
usual rodent species. On the other hand, the judgment
that rodents are an inappropriate model is based on the
lack of accumulation of formate after exposure to large
methanol doses. Although formate has been strongly im-
plicated in the acidosis and ocular toxicity that arise in
primates following acute exposure, there is no guarantee
that chronic exposure to low doses of methanol would
produce sufficientblood concentrations offonnatetocause
oculartoxicity orthatformatepersewould beresponsible
for the toxic responses, if any, that result from chronic
low-dose exposure.
Given the expense ofperforming any chronic toxicity
study and the additional costs when primates are stud-
ied, it seems prudent to base the choice of an animal
model on objective evidence to the maximum extent
possible. Usefulinputforthischoice canbederivedfrom
comparisons of methanol pharmacokinetics among ro-
dents, subhumanprimates, andhumansfollowingshort-
term exposures by inhalation. In particular, proper de-
sign of such studies using rodents and subhuman pri-
mates couldmakeitpossibletodevelop aphysiologically
based pharmacokinetic model for methanol of the kind
employedbyAndersenandhisco-workers(9,10)intheir
studies of styrene and other chemicals. A mechanistic
distribution and disposition model ofthis kind could be
scaled-up on a purely scientific basis using data specific
tomethanolandtherelevantspeciestopredicttheblood
concentrations of methanol or formate expected in hu-
mans, even under conditions of exposure that are not
ethically attainable in direct tests. It may be possible
to use such a model to identify conditions of exposure
forrodentsthat, byvirtueofadjustedtemporalpatterns
ofexposure and/or airborne concentrations, would pro-
duce blood concentrations of methanol and formate in
the rodent that mirror those predicted to occur in pri-
mates and humans at or above the current TLV. Se-
lection of dose levels for chronic studies on this basis
would provide a unique way to avoid problems associ-
ated with the use of maximum tolerated doses for ro-
dents that may have little or no relevance to human
exposure conditions.
1,3-Butadiene
The potential for occupational exposures to 1,3-bu-
tadiene exists in the synthetic rubber industry where
this colorless gas is employed as a comonomer in the
production process. Several retrospective mortality
studies of workers in this industry have indicated sig-
nificantly less overall cancer mortality than occurs in
the general population; however, these studies also re-
vealed a possible association between 1,3-butadiene ex-
posure and increased risk of death from lymphatic and
hematopoietic neoplasms (11-13).
The findings of two recent bioassays have demon-
strated that 1,3-butadiene is a rodent carcinogen, but
some striking species differences in toxicity were ob-
served. Sprague-Dawley ratsexposedtorelativelyhigh
concentrations of1,3-butadiene (1000-8000 ppm) exhib-
ited significant increases in a variety ofsolid tissue tu-
mors, including mammary, thyroid, zymbal, and pan-
creatic, as well as uterine and testicular neoplasms,
some of which were observed only in the highest dose
group (14). In sharp contrast, exposure ofB6C3F1 mice
to 625 or 1250 ppm resulted in a significant elevation in
theincidenceofhemangiosarcomas, bronchialadenomas
and carcinomas, papillomas of the forestomach, mam-
mary adenomas, and ovarian tumors. The incidence of
malignant lymphoma in mice, apparently ofthymic or-
igin, exceeded 50% in the males exposed to the highest
concentration and forced termination ofthe study after
60 to 61 weeks of study for both dose groups (15).
The potential association of 1,3-butadiene exposure
and lymphoma/leukemiain man has heightened concern
regarding the occurrence of lymphoma in the treated
B6C3F1 mice. However, it is currently not at all clear
whether the mouse or the rat is the most appropriate
animal model for assessing human risk from butadiene
exposure. Studies ofthe mechanisms bywhich chemical
exposures induce lymphomas in laboratory mice have
been hampered by the ubiquitous presence of endoge-
nous type C retroviruses (MuLV) that are invariably
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associated with spontaneous lymphoma and leukemiain
these animals. Consequently, it has not yet been pos-
sible to determine therespective contributions ofchem-
ical exposure and the endogenous retrovirus to murine
leukemogenesis. Strain variations in MuLV expression
and the spontaneous incidence of leukemia/lymphoma
are both large, and it is clear that the presence of the
endogenous virus per se does not produce the disease
but is a critical part of a multifactorial process. Thus,
cross-species differences inretroviral background could
have an important bearing on butadiene toxicity and
the evaluation ofpotential risk to humans.
Type C retroviruses have been identified as the etio-
logic agents in a majority ofspontaneous leukemias oc-
curring in many animal species (16). In addition, ad-
vances in immunobiology and molecular biology have
permitted the isolation and definitive characterization
of a human type C retrovirus, which is involved in the
etiology of adult T-cell lymphomas and leukemias and
has been demonstrated to transform human cells in cul-
ture (17-22). Although a large majority of individuals
can be shown to express the virus (greater than 87% in
one study), not all individuals who express the virus
incur the disease. This strongly suggests that external
factors, possibly of environmental origin, also play a
role in the expression oflymphoma in these individuals
(23,24).
A thorough evaluation of the mouse bioassay data
requires an investigation into the possibility ofindirect
mechanisms of action such as viral activation that may
be induced by toxic effects in target organs other than
thethymus. Forexample, bonemarrowinjuryis known
toplayanessentialroleinthepathogenesis ofradiation-
induced murine leukemogenesis (25-27). It has also
been implicated in certain chemically induced murine
lymphomas (28).
Studies in progress at CIIT have begun to shed light
onthe mechanisms underlyingbutadiene leukemogenesis.
Thymic lymphoma was found to be the major cause of
death in B6C3F1 mice chronically exposed to 1,3-buta-
dieneatanairborne concentrationof1250ppm. Thisstudy
confirmed the previous findings ofHuff et al. (15). These
lesions were encountered as early as 25 weeks after the
initiation of exposure. The lymphomas were ofT-cell or-
igin and expressed significantly increased levels ofMuLV
(29). Furthermore, the bone marrow has been identified
as an important target for 1,3-butadiene toxicity in these
mice. Thisisconsistentwiththeresultsofpreviousstudies
of radiation-induced murine thymic lymphoma that indi-
cated that bone marrow damage is an essential prereq-
uisite for lymphoma development. The specific nature of
the bone marrow damage is manifested by a macrocytic-
megaloblastic anemia, cytogenetic abnornalities, and al-
terations in hematopoietic stem cell development (30).
Thequestionofwhetherornotendogenousretrovirus
expression is essential in the development oflymphoma
inbutadiene-exposed mice can be addressed by exploit-
ing the marked strain variations in retrovirus expres-
sion noted earlier. Unlike the B6C3F1 mouse, NIH
Swiss mice possess a unique, proviral background in
which MuLV gene sequences are truncated (31-33).
Consequently, endogenous ecotropic MuLV virus has
neverbeen detected inthis strain. Comparative studies
of 1,3-butadiene-exposed NIH Swiss and B6C3F1 mice
can provide a presumptive answer to this important
question. Findings from the first of a series of studies
in progress at CIIT have revealed that 1,3-butadiene
exposure induces the same megaloblastic anemia bone
marrow damage in NIH Swiss mice as was observed in
the B6C3F1 mouse (34). These studies indicate that the
bone marrow is an important murine target organ for
1,3-butadiene toxicity, irrespective of MuLV expres-
sion. Ironically, more precise knowledge of the mech-
anismofbutadieneoncogenesiscouldleadeithertocom-
plete invalidation of the murine lymphoma model for
human risk assessment purposes or, alternatively, to
the identification ofspecific human subpopulations that
maybe particularly sensitive to the effects ofexposure.
Unleaded Gasoline
A 2-year inhalation study ofgasoline toxicity in rats
and mice revealed a significant increase in tumors of
the kidney, but only amongthe male rats (35,36). Dose-
dependent nephrotoxicity, including the appearance of
hyalinedroplets (abnormalamountsofintracellularpro-
tein) intheproximalportions ofthekidneytubules, was
also noted exclusively in the male rats. Although cur-
rent regulatory practice would consider humans to be
potentially as sensitive to such effects as the male rat,
it hasbeen suggested thatthemaleratmaybe uniquely
predisposed to renal toxicity from hydrocarbon expo-
sure and may be an inappropriate animal model for hu-
man risk assessment. In vivo-in vitro DNA repair as-
says of unleaded gasoline have failed to produce evi-
dence of genotoxic activity in isolated kidney cells of
the male rat (37). These studies suggest that a direct
genetic mechanism may not be operative. Knowledge
ofthe actualmechanisms bywhichhydrocarbonsinduce
toxicity and tumors in the male rat kidney will be es-
sential to the interpretation of bioassay findings and
their implications for human risk assessment.
Unleaded gasoline and otherpetroleumproducts con-
tain five classes ofhydrocarbons: normal paraffins, iso-
paraffins, cycloparaffins, olefins, and aromatics. The
paraffins are saturated aliphatic hydrocarbons; the ole-
fins and aromatics are unsaturated. Studies ofthe var-
ious component fractions of unleaded gasoline have in-
dicated that the nephrotoxic activity resides primarily
in those fractions that contain saturated branched ali-
phatic compounds (38). A series of28-day gavage stud-
ies have revealed that the highly branched hydrocar-
bons such as 2,2,4-trimethylpentane and 2,2,5-tri-
methylhexane are the most active nephrotoxins in male
rats (39). Studies ofotherhydrocarbon-containing com-
pounds such asjet fuel, Stoddard Solvent, decalin, and
methyl isobutyl ketone have also shown a similar pat-
tern of nephrotoxicity in the male rat, but no notable
effects in other species such as the dog or monkey (40).
The accumulation of proteinaceous material in the
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form of hyaline droplets within the lysosomes of the
proximal tubules ofthe male rat kidney was a common
feature in these experiments. These findings suggest
that renal protein handling is compromised by hydro-
carbon exposure. The glomerulus is the functional unit
of the kidney nephron that selectively filters low mo-
lecular weight proteins from the plasma. Most filtered
proteins are not excreted in the urine but rather are
reabsorbed bythe proximal tubule cells where catabolic
enzymes in the lysosome organelles degrade them into
amino acids. However, untreated male rats exhibit pro-
teinuria, with over 50% of the excreted protein con-
sistingofa-2u-globulin. This low molecularweight, sex-
dependent protein is synthesized in the liver under an-
drogenic induction and then completely filtered from
plasma at the glomerulus (41-43). Plasma levels ofthis
protein in the female rat are very low, and it has not
been detected in mice orhumans. Although a large por-
tion of the filtered a-2u-globulin is reabsorbed by the
proximal tubules and recycled (44), its appearance in
the urine ofthe male rat suggests that the reabsorptive
capacity ofthe proximal tubule for this protein may be
limited.
Alden et al. (40) have shown a clear correlation be-
tween toxicity and oa-2u-globulin accumulation in the
kidney using decalin as a model hydrocarbon. Studies
with a specific antibody to this protein demonstrated
that decalin-induced hyaline droplets in the male rat
kidneywerecomposedofa-2u-globulin. Kloss etal. (45),
usinganother radiolabeled hydrocarbon, 2,2,4-[14C]-tri-
methylpentane (TMP), showed 10-fold greater amounts
ofradiolabel in male rat kidneys than in female rat kid-
neys and no such accumulation in any organ of male
mice. Additional experiments by these investigators
have demonstrated that modulation of cytochrome P-
450 metabolism alters the in vivo disposition of TMP,
with inhibited metabolism leading to reduced renal re-
tention ofTMP. These findings suggest that production
of a reactive metabolite of TMP in the liver may play
an important role in the induction ofnephrotoxicity via
the following complex mechanism (46).
After oral exposure, TMP enters the male rat liver,
where it is initially hydroxylated at C-4. Although this
4-hydroxyTMP metabolite could then be quickly at-
tacked by conjugative enzymes that would deactivate
the molecule and target it for urinary excretion, its
highly hydrophobic and bulky tertiary butyl group may
make the molecule sufficiently lipophilic to be retained
within the endoplasmic reticulum longenough for a sec-
ondhydroxylation (at C-5) to occur. This diolmetabolite
would bequickly oxidized to form areactive a-hydroxy-
aldehyde metabolite of TMP, of which only a small
amount is further oxidized and decarboxylated to pro-
duce CO2. The reactive aldehyde metabolite could then
form Schiffbase adducts with the a-2u-globulin protein
as it is being synthesized in the liver. The altered pro-
tein would then be secreted by the liver and filtered at
the glomerulus of the kidney, where the covalent as-
sociation ofthis protein with the TMP metabolite may
precludeits effective degradationbythe lysosomal pep-
tidases. Continuous loading of the lysosomes with al-
tered protein would lead to hyaline droplet formation,
disruption of lysosome integrity, and intracellular re-
lease of catabolic peptidases, resulting in cell damage
and death. These events would then stimulate a wave
ofrestorative cell proliferation, which in turn could ac-
count for the hyperplastic and neoplastic kidney lesions
induced by chronic exposure to unleaded gasoline and
other hydrocarbons. Recent studies at CIIT have con-
firmed that TMP produces a marked increase in cell
turnover in renal tubule epithelium ofmale rats (47).
At present, the details ofthis complex mechanism for
hydrocarbon nephrotoxicity require additional valida-
tion in the laboratory. However, available information
indicatesthefundamentalimportanceforunderstanding
toxic mechanisms in interpretations of the discrepant
bioassay data. Ifthe nephrotoxicity of gasoline can be
definitively linked to atoxicological event thatis unique
to the male rat, it can be concluded that similar events
arenotlikelytooccurinhumans. Researchonthemech-
anisms of action of hydrocarbons may also provide im-
portant insights into how other chemicals without de-
monstrable genotoxic activity produce tumors in animal
test systems.
Formaldehyde
Exposure to formaldehyde has been associated with
a variety ofadverse health effects (48-50). It is known
to cause eye, nose, and throat irritation, aswellasder-
mal irritation and allergic contact dermatitis. Formal-
dehyde is a weak mutagen in some strains ofbacteria,
fungi, and Drosophila larvae. It is also a weak initiator
and weak promoter of cell transformation in the C3H/
1OT1/2 cell culture system. Formaldehyde induces
DNA-protein cross-links in cultures of bacterial and
mammalian cells, and this phenomenon has now been
detected in the nasal tissues ofrats exposed to formal-
dehyde vapor via inhalation (51). An important finding
reported by Kerns etal. (52) wasthatchronicinhalation
exposure ofFischer 344 rats to 14.3 ppm formaldehyde
gas for over 2 years induced a 50% incidence of nasal
cavity squamous cell carcinomas, an otherwise rare tu-
mor in rodents. In sharp contrast, only 1% ofthe mice
identically exposed to 14.3 ppm and rats exposed to 5.6
ppm exhibited this tumor upon necropsy.
To properly assess the potential carcinogenic effects
offormaldehyde exposure in humans, it is critically im-
portant that the already available extensive data base
regarding formaldehyde toxicity be optimally used. A
keyissue concerns the form ofthe relationship between
the doses administered during the course of a bioassay
and the corresponding doses delivered to specific mac-
romolecules innasaltargettissues. Regulatoryagencies
continue to rely on the assumption that administered
and delivered formaldehyde doses are proportional, de-
spite a considerable body ofevidence thatindicatesthat
this is not the case.
Short-term inhalation studies have now established
that the amount offormaldehyde that binds covalently
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to the DNA of replicating cells in the respiratory epi-
thelium ofthe rat nasal cavity is nonlinearly related to
the airborne formaldehyde concentration (51,53). Fol-
lowing two 6-hr exposures to formaldehyde, signifi-
cantly less binding occurred at airborne concentrations
of 2 ppm or below than would be predicted by linear
extrapolation from the binding observed at concentra-
tions of 6 ppm or more. At 2 ppm, the ratio of the
predicted level of binding (assuming linearity) to the
observed level was approximately 3.5. At 0.3 ppm, this
ratio was even larger (approximately 5.6). These ratios
represent the factors by which the delivered dose in
target tissue is overestimated when strict linear pro-
portionality between the administered and delivered
doses is assumed.
Related mechanistic studies have demonstrated that
exposure ofrats to formaldehyde via inhalation induces
the respiratory depression reflex (54), inhibits mucoci-
liary clearance (55,56), inhibits intracellularmetabolism
of formaldehyde (53), and stimulates cell proliferation
(54,57), all as nonlinear functions of the airborne for-
maldehyde concentration. Inasmuch as each of these
phenomena appears to be an important controlling fac-
tor in the relationship between administered and deliv-
eredformaldehyde doses (58), thenonlinearrelationship
between covalent binding to DNA in target tissues and
airborne concentration is not unexpected.
The respiratory depression reflex mediates the in-
haled dose, andmucociliary clearancemediates thefrac-
tionoftheinhaleddosethatpenetratesthemucouslayer
covering underlying epithelial cells in the nasal cavity.
Intracellular metabolism modulates the fraction of for-
maldehyde entering these cells that remain free to bind
with cellular macromolecules including DNA. Impor-
tant in this regard is the fact that formaldehyde is an
essential biochemical that is normally present in all liv-
ing cells. It is not surprising that efficient metabolic
pathways exist for its detoxication, at least at low air-
borne concentrations. The rate of cell replication con-
trols the fraction of DNA that is single stranded, and
it is known that formaldehyde binds covalently only to
single-stranded DNA (59,60).
The concept of delivered dose provides a convenient
vehicle whereby these and similar biological observa-
tions can be incorporated directly into the risk assess-
ment process in a meaningful and effective way. For
example, use of the covalent binding observations as
themeasure ofexposure inseveralcommonlyuseddose-
response models has been shown to result in low-dose
cancer risk estimates that are considerably lower than
corresponding estimates based exclusively on airborne
concentration, irrespective ofthe dose-response model
employed (61). At 1 ppm formaldehyde, the maximum
likelihood estimate ofriskobtained with thethree-stage
version of the multistage model was reduced over 50-
fold.
However, it is important to recognize that the use of
data obtained in short-term mechanistic studies forrisk
assessment rests on anumber ofassumptions which are
as yet unverified. For example, it must be assumed at
present that such data are representative ofconditions
throughout the course ofa long-term bioassay. The as-
sumption that steady-state distribution and pharma-
cokinetics are achieved rapidly can only be tested with
laboratory experiments that cover more extended pe-
riodsofexposure. Itmust also beassumed that covalent
binding to DNA or concentration of specific DNA ad-
ducts plays an important role in tumor induction. Hoel
et al. (62) have argued convincingly that it is likely to
be "biologically more meaningful to relate tumor re-
sponse to concentrations ofspecific DNA adducts in the
target tissue than it is to relate tumor response to the
administered dose of a chemical." However, the as-
sumption that such measures are directly relevant to
tumor induction still remains to be validated in the lab-
oratory.
Itshould alsobe emphasized thatdifferences between
species in any ofthe diverse factors that determine the
quantitative relationship between delivered and ad-
minstered doses can produce corresponding differences
inthedelivereddose andtheattendantcancerrisk, even
when the different species are identically exposed to
the same administered dose. For example, the remark-
able disparity in tumor incidence among rats and mice
identically exposed to 14.3 ppm in the formaldehyde
bioassay can be explained by the corresponding differ-
ence between these species in the inhaled dose (54).
Comparative studies with species that bear a closer re-
semblance to humans than rodents (i.e., subhuman pri-
mates) can assist in establishing the relevance of the
data obtained with rodent models to the assessment of
human risk from formaldehyde exposure.
Summary
The central theme that emerges from this review of
some CIHT research is that interspecies differences in
responses to chemical exposures should not simply be
ignored infavorofadhocgeneralizations fromtheworst
case. Such differences provide important clues to the
underlying mechanisms by which chemicals exert their
toxic effects. These differences must be carefully stud-
ied in depth and then explained in mechanistic terms
before truly valid and scientifically defensible judg-
ments regarding their relevance to human risk assess-
ment are possible. In each case, many factors must be
considered, rangingin scope fromphysiologic responses
of the whole animal to specific chemical reactions with
critical macromolecules in both target and nontarget
organs. Identification ofthe actualmechanismsinvolved
in chemically induced toxicity should eventually lead to
the development of risk assessment models that more
adequatelyreflecttheuniquebiologicalandtoxicological
characteristics of different species-chemical combina-
tions.
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